Filing Details
- Accession Number:
- 0001209191-23-042937
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-20 17:47:53
- Reporting Period:
- 2023-07-17
- Accepted Time:
- 2023-07-20 17:47:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829958 | K. Suresh Durgam | C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-07-17 | 1,842 | $65.00 | 21,262 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2023.
Billionaire Hedge Funds
